Under today’s regulatory landscape, Post-Market Clinical Follow-Up (PMCF) is no longer a procedural requirement—it is a strategic pillar of clinical evidence generation.
Manufacturers must continuously demonstrate that their medical devices maintain an acceptable safety, performance, and risk–benefit profile once they are on the market. This expectation has been reinforced by the EU Medical Device Regulation, which places strong emphasis on the collection of high-quality post-market clinical data.
However, many PMCF activities still rely on fragmented data collection methods that lack methodological rigor and traceability. In an environment of increasing scrutiny from Notified Bodies, this approach is becoming increasingly difficult to defend.
This is where 1Survey+ provides a structured and compliant approach to PMCF data collection.
The Challenge of Modern PMCF Programs
PMCF is intended to confirm the continued safety and performance of a device throughout its lifecycle. In practice, manufacturers often struggle with several operational and regulatory challenges:
- Limited access to real-world clinical data
- Low clinician engagement in follow-up studies
- Fragmented survey and feedback systems
- Weak audit trails for collected data
- Difficulty linking survey results to clinical endpoints
- Time-consuming reconstruction of evidence during audits
When these challenges occur, PMCF programs risk producing data that is difficult to use in Clinical Evaluation Reports (CER), risk management updates, or SSCP documentation.
The result is often additional regulatory scrutiny and requests for further evidence.
PMCF Surveys as a Scalable Evidence Strategy
Structured surveys are one of the most scalable ways to collect real-world clinical evidence, particularly for:
- Clinician experience and performance feedback
- Patient-reported outcomes (PROs)
- Long-term device follow-up
- Usability and training validation
- Real-world performance observations
However, for survey data to contribute to regulatory documentation, the methodology and infrastructure must meet a higher standard than generic survey tools.
This is where clinical-grade survey methodology becomes essential.
How 1Survey+ Enables Clinical-Grade PMCF Data Collection
1Survey+ was designed specifically to support regulatory-grade evidence generation for the medical device sector.
Rather than functioning as a simple survey tool, the platform provides an infrastructure for structured PMCF data capture aligned with regulatory expectations.
Key capabilities include:
Intended-Use Driven Survey Design
PMCF questionnaires can be structured around:
- Intended use and intended purpose
- Risk-benefit validation
- Device performance endpoints
- Clinical workflow integration
This ensures collected data aligns directly with clinical evaluation objectives.
Certified Timestamping and Traceability
Every data entry within 1Survey+ includes:
- Certified timestamps
- Traceable audit trails
- Secure documentation of modifications
This creates a defensible record of when and how evidence was generated—an increasingly important requirement during regulatory inspections.
Structured Endpoint Evaluation
The platform allows manufacturers to collect structured clinical feedback on:
- Performance outcomes
- Safety observations
- Device usability
- Procedural variability
- Patient impact
This allows PMCF data to contribute meaningfully to risk management and benefit-risk reassessment.
Scalable Global Data Collection
PMCF programs often span multiple hospitals and regions. 1Survey+ enables standardized deployment across sites, ensuring:
- Consistent methodology
- Comparable datasets
- Harmonized data analysis
- Centralized oversight
This scalability makes PMCF programs easier to manage and expand.
Combining Technology with CRO Expertise
One of the key advantages of working with 1MED is that 1Survey+ is not delivered as standalone software.
It is supported by a specialized MedTech CRO team with expertise in:
- PMCF strategy development
- Clinical methodology design
- Endpoint evaluation
- Regulatory documentation alignment
- Clinical evaluation and risk management integration
This ensures that survey programs are not only technically robust but also aligned with broader regulatory and clinical evidence strategies.
The result is a PMCF program that is both operationally efficient and scientifically defensible.
Supporting the Full Clinical Evidence Lifecycle
When integrated into a manufacturer’s clinical strategy, PMCF data collected through 1Survey+ can support:
- Clinical Evaluation Reports (CER)
- Risk management updates
- Summary of Safety and Clinical Performance (SSCP)
- Real-world evidence generation
- Health economic value analysis
- Market expansion strategies
By capturing structured real-world data, manufacturers can continuously reinforce the evidence supporting their device.
From Compliance Activity to Strategic Evidence
Too often, PMCF is treated as a regulatory obligation rather than an opportunity.
Yet well-designed PMCF programs can provide valuable insight into:
- Long-term device performance
- Real-world patient outcomes
- Usability optimization
- Training effectiveness
- Market differentiation
1Survey+ allows manufacturers to turn PMCF from a compliance exercise into a strategic evidence-generation tool.
Building Defensible Real-World Evidence
In an increasingly demanding regulatory environment, the question is no longer whether manufacturers collect post-market data.
The real question is whether that data is methodologically sound, traceable, and defensible.
By combining clinical expertise with a purpose-built digital infrastructure, 1Survey+ enables manufacturers to generate high-quality PMCF evidence that stands up to regulatory scrutiny and supports the full lifecycle of medical devices.
Because in modern MedTech regulation, evidence is not simply collected.
It must be designed, captured, and preserved with integrity from the start.
Discover more about 1Survey+ and book a demom here demo@1med.net
